Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 20, 2026

Intel's AI Comeback: CEO Reveals Insatiable CPU Demand As Customers Bulk Up Orders

View original at finance.yahoo.com
Intel's AI Comeback: CEO Reveals Insatiable CPU Demand As Customers Bulk Up Orders Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Intel improved 18A yields with monthly progress of 7% to 8%, helping attract outside customer interest in Intel's foundry

    60% confidence
  • Intel rated Neutral with a price target of $124.00

    60% confidence
  • One customer wanted to triple its CPU forecast, but Intel needs several quarters to catch up to meet that demand

    60% confidence
  • Google is an important partner and Intel wants to work with 'winners' by helping customers succeed

    60% confidence
  • Intel's foundry business is a strategic national asset because more than 90% of advanced processors are made outside the U.S.

    60% confidence
  • Intel's 14A process could reach risk production in 2028 and volume production in 2029, on a timeline to compete with TSMC

    60% confidence
  • Intel is simplifying its roadmap, bringing engineering closer to customers, and rebuilding talent to restore competitiveness

    60% confidence
  • Multiple customers are working with Intel on foundry services (declined to name Apple but implied its inclusion)

    60% confidence
  • Intel's XPU combined with SambaNova's data-flow architecture can deliver better performance and lower power consumption

    60% confidence
  • Intel rated Buy with a price target of $140.00

    60% confidence
  • Intel once led the data center market but lost that position after product and execution mistakes

    60% confidence
  • AI inference is increasing CPU demand as customers need more processors to manage orchestration, agents, and reinforcement learning

    60% confidence
  • Intel rated Buy with a price target of $130.00

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com